FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208390697> ?p ?o ?g. }

• W3208390697 abstract "The emergence of SARS-CoV-2 variants of concern (VOC) requires adequate coverage of vaccine protection. We evaluated whether a SARS-CoV-2 spike ferritin nanoparticle vaccine (SpFN), adjuvanted with the Army Liposomal Formulation QS21 (ALFQ), conferred protection against the Alpha (B.1.1.7), and Beta (B.1.351) VOCs in Syrian golden hamsters. SpFN-ALFQ was administered as either single or double-vaccination (0 and 4 week) regimens, using a high (10 μg) or low (0.2 μg) dose. Animals were intranasally challenged at week 11. Binding antibody responses were comparable between high- and low-dose groups. Neutralizing antibody titers were equivalent against WA1, B.1.1.7, and B.1.351 variants following two high dose vaccinations. Dose-dependent SpFN-ALFQ vaccination protected against SARS-CoV-2-induced disease and viral replication following intranasal B.1.1.7 or B.1.351 challenge, as evidenced by reduced weight loss, lung pathology, and lung and nasal turbinate viral burden. These data support the development of SpFN-ALFQ as a broadly protective, next-generation SARS-CoV-2 vaccine." @default.
• W3208390697 created "2021-11-08" @default.
• W3208390697 creator A5002187104 @default.
• W3208390697 creator A5004585142 @default.
• W3208390697 creator A5005601710 @default.
• W3208390697 creator A5007851081 @default.
• W3208390697 creator A5010131062 @default.
• W3208390697 creator A5011769657 @default.
• W3208390697 creator A5014472419 @default.
• W3208390697 creator A5014869007 @default.
• W3208390697 creator A5015703217 @default.
• W3208390697 creator A5018060592 @default.
• W3208390697 creator A5019474861 @default.
• W3208390697 creator A5022694965 @default.
• W3208390697 creator A5022895367 @default.
• W3208390697 creator A5023894970 @default.
• W3208390697 creator A5025952046 @default.
• W3208390697 creator A5026217717 @default.
• W3208390697 creator A5027624990 @default.
• W3208390697 creator A5029217668 @default.
• W3208390697 creator A5029401784 @default.
• W3208390697 creator A5031713882 @default.
• W3208390697 creator A5032154596 @default.
• W3208390697 creator A5032268939 @default.
• W3208390697 creator A5035932988 @default.
• W3208390697 creator A5036265394 @default.
• W3208390697 creator A5037135164 @default.
• W3208390697 creator A5037892885 @default.
• W3208390697 creator A5038720311 @default.
• W3208390697 creator A5039272834 @default.
• W3208390697 creator A5039786822 @default.
• W3208390697 creator A5040895702 @default.
• W3208390697 creator A5041344472 @default.
• W3208390697 creator A5044200741 @default.
• W3208390697 creator A5045593221 @default.
• W3208390697 creator A5045969471 @default.
• W3208390697 creator A5047909325 @default.
• W3208390697 creator A5048593024 @default.
• W3208390697 creator A5053176019 @default.
• W3208390697 creator A5054916608 @default.
• W3208390697 creator A5055341298 @default.
• W3208390697 creator A5059676339 @default.
• W3208390697 creator A5060102425 @default.
• W3208390697 creator A5061200264 @default.
• W3208390697 creator A5066093013 @default.
• W3208390697 creator A5066873917 @default.
• W3208390697 creator A5067769747 @default.
• W3208390697 creator A5069501174 @default.
• W3208390697 creator A5072305151 @default.
• W3208390697 creator A5073568865 @default.
• W3208390697 creator A5075447524 @default.
• W3208390697 creator A5079094688 @default.
• W3208390697 creator A5083256182 @default.
• W3208390697 creator A5086361126 @default.
• W3208390697 creator A5087258675 @default.
• W3208390697 creator A5089153612 @default.
• W3208390697 creator A5090836877 @default.
• W3208390697 creator A5091188983 @default.
• W3208390697 date "2021-10-28" @default.
• W3208390697 modified "2023-10-12" @default.
• W3208390697 title "A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge" @default.
• W3208390697 cites W3009912996 @default.
• W3208390697 cites W3012831148 @default.
• W3208390697 cites W3013273499 @default.
• W3208390697 cites W3025871232 @default.
• W3208390697 cites W3027204812 @default.
• W3208390697 cites W3036887118 @default.
• W3208390697 cites W3045734160 @default.
• W3208390697 cites W3046061621 @default.
• W3208390697 cites W3081741393 @default.
• W3208390697 cites W3088521725 @default.
• W3208390697 cites W3092136311 @default.
• W3208390697 cites W3099530525 @default.
• W3208390697 cites W3110900875 @default.
• W3208390697 cites W3121332187 @default.
• W3208390697 cites W3121365103 @default.
• W3208390697 cites W3127311730 @default.
• W3208390697 cites W3130984893 @default.
• W3208390697 cites W3132982761 @default.
• W3208390697 cites W3133794453 @default.
• W3208390697 cites W3133980772 @default.
• W3208390697 cites W3135383916 @default.
• W3208390697 cites W3135915663 @default.
• W3208390697 cites W3137469790 @default.
• W3208390697 cites W3139036184 @default.
• W3208390697 cites W3153636933 @default.
• W3208390697 cites W3157738987 @default.
• W3208390697 cites W3168503506 @default.
• W3208390697 cites W3175809015 @default.
• W3208390697 cites W3197662000 @default.
• W3208390697 cites W3203359228 @default.
• W3208390697 cites W3209429470 @default.
• W3208390697 cites W3124826276 @default.
• W3208390697 doi "https://doi.org/10.1038/s41541-021-00392-7" @default.
• W3208390697 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8553838" @default.
• W3208390697 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34711815" @default.
• W3208390697 hasPublicationYear "2021" @default.
• W3208390697 type Work @default.
• W3208390697 sameAs 3208390697 @default.
• W3208390697 citedByCount "42" @default.

• next